| Colleen Ann Schlangen, PT | |
|
2870 Juniper Dr, Lewiston, ID 83501-4720 | |
| (208) 746-2855 | |
| Not Available |
| Full Name | Colleen Ann Schlangen |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2870 Juniper Dr, Lewiston, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023203817 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT650 (Idaho) | Primary |
| 225100000X | Physical Therapist | PT00006075 (Washington) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Ann Schlangen, PT 25117 Sw Parkway Ave, Suite D, Wilsonville, OR 97070-9697 Ph: (503) 570-3665 | Colleen Ann Schlangen, PT 2870 Juniper Dr, Lewiston, ID 83501-4720 Ph: (208) 746-2855 |
News Archive
The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible are reviewed in the peer-reviewed journal Human Gene Therapy.
"Young men undergoing treatment for cancer often want to know how the disease and its treatment affect their chances of fathering healthy children. Our large-scale study shows that there is a slightly higher risk of deformities, but the actual risk of having a child with deformities is nevertheless extremely low. I think this is good news!"
A new report finds that 509,025 (9.17%) public high school students in 24 states experienced homelessness in spring 2019 - three times the number recognized by the states' education agencies. This under-recognition creates gaps in funding and services needed by this vulnerable population.
Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
› Verified 4 days ago
Dr. Hannah Gibbs, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 615 21st St, Lewiston, ID 83501 Phone: 208-413-7062 | |
Kyle Joseph Knigge, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 328 Warner Dr Ste 8, Lewiston, ID 83501 Phone: 208-746-7573 | |
Institute Of Physical Therapy And Fitness Physical Therapist Medicare: Medicare Enrolled Practice Location: 678 Southway Ave, Lewiston, ID 83501 Phone: 208-746-1418 Fax: 208-746-4123 | |
Gretchen Gay Gundy, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3317 12th St, Lewiston, ID 83501 Phone: 208-748-3258 | |
Keith R Drury, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 678 Southway Ave, Lewiston, ID 83501 Phone: 208-746-1418 Fax: 208-746-4123 | |
Peak Performance Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 216 Larkspur Ln, Lewiston, ID 83501 Phone: 208-746-0455 Fax: 208-746-0688 |